000 | 03483nam a22003734a 4500 | ||
---|---|---|---|
001 | 0000114155 | ||
005 | 20171002060028.0 | ||
006 | m u | ||
007 | cr cn||||||||| | ||
008 | 090224s2009 dcuaf sb 001 0 eng | ||
010 | _z 2009008069 | ||
016 | 7 |
_z101497162 _2DNLM |
|
020 | _z9781555814397 | ||
020 | _z1555814395 | ||
035 | _a(CaPaEBR)ebr10346895 | ||
035 | _a(OCoLC)646855121 | ||
040 |
_aCaPaEBR _cCaPaEBR |
||
050 | 1 | 4 |
_aRM411 _b.A57556 2009eb |
082 | 0 | 4 |
_a615/.7924 _222 |
245 | 0 | 0 |
_aAntiviral research _h[electronic resource] : _bstrategies in antiviral drug discovery / _cedited by Robert L. LaFemina. |
260 |
_aWashington, DC : _bASM Press, _cc2009. |
||
300 |
_axiii, 373 p., [24] p. of plates : _bill. (some col.). |
||
504 | _aIncludes bibliographical references and index. | ||
505 | 0 | _aAntiherpesviral DNA polymerase inhibitors / Donald M. Coen -- Entry inhibitors of human immunodeficiency virus / Masanori Baba -- Human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors / Dirk Jochmans ... [et al.] -- Nucleoside analogue inhibitors of human immunodeficiency virus reverse transcriptase / Jérôme Deval and Matthias Götte -- Integrase as a novel target for the inhibition of human immunodeficiency virus type 1 infection : current status and future perspectives / Linos P.R. Vandekerckhove ... [et al.] -- Human immunodeficiency virus type 1 tat and rev as potential targets for drug development / Sergei Nekhai and Kuan-Teh Jeang -- Inhibitors of the human immunodeficiency virus protease / Jorge L. Martinez-Cajas and Mark A. Wainberg -- Hepatitis C virus polymerase as a target for antiviral drug intervention : non-nucleoside inhibitors / Yaya Liu, Yupeng He, and Akhteruzzaman Molla -- Nucleoside analog inhibitors of hepatitis C viral replication / Steven S. Carroll and Robert L. LaFemina -- | |
505 | 0 | _aAntiviral targets in orthopoxviruses / Mark N. Prichard and Earl R. Kern -- Influenza virus antiviral targets / Gillian M. Air and Wayne J. Brouillette -- Developments in the search for small-molecule inhibitors for treatment of severe acute respiratory syndrome coronavirus / Dale L. Barnard and Yohichi Kumaki -- Antiviral treatment of flaviviruses / Justin G. Julander -- Clinical aspects of hepatitis C virus infection / David Durantel and Fabien Zoulim -- Microbicides : molecular strategies for prevention of sexually transmitted viral disease / Raina N. Fichorova -- Phenotypic susceptibility assays for human immunodeficiency virus type 1 / Neil T. Parkin, Eoin Coakley, and Christos J. Petropoulos -- Metabolism of antiviral nucleosides and nucleotides / Adrian S. Ray and Michael J.M. Hitchcock -- Targeting the interferon response for antiviral therapy / Michael D. Robek -- Toll-like receptors : novel molecular targets for antiviral immunotherapy / Raymund R. Razonable, Albert Eid, and Martin Henault -- New herpes simplex virus replication targets / Sandra K. Weller. | |
533 |
_aElectronic reproduction. _bPalo Alto, Calif. : _cebrary, _d2013. _nAvailable via World Wide Web. _nAccess may be limited to ebrary affiliated libraries. |
||
650 | 0 | _aAntiviral agents. | |
655 | 7 |
_aElectronic books. _2local |
|
700 | 1 | _aLaFemina, Robert L. | |
710 | 2 | _aAmerican Society for Microbiology. | |
710 | 2 | _aebrary, Inc. | |
856 | 4 | 0 |
_uhttp://site.ebrary.com/lib/daystar/Doc?id=10346895 _zAn electronic book accessible through the World Wide Web; click to view |
908 | _a170314 | ||
942 | 0 | 0 | _cEB |
999 |
_c103305 _d103305 |